PRMT1 and diffuse large B-cell lymphoma: Additionally, a high expression of NUCB1, COPG1, CD44, ALDH18A1, IRF4, SCRN1, B2M, and PRMT1 mRNAs was associated with the worst overall survival (OS) for patients with DLBCL (Figure 4G–I and Figure S5A–L).